Teacher Retirement System of Texas cut its stake in Humana Inc. (NYSE:HUM - Free Report) by 66.0% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 21,550 shares of the insurance provider's stock after selling 41,782 shares during the quarter. Teacher Retirement System of Texas' holdings in Humana were worth $5,520,000 as of its most recent SEC filing.
Several other large investors also recently modified their holdings of the stock. Retirement Planning Co of New England Inc. raised its position in shares of Humana by 7.0% in the fourth quarter. Retirement Planning Co of New England Inc. now owns 1,317 shares of the insurance provider's stock valued at $337,000 after purchasing an additional 86 shares during the period. KLP Kapitalforvaltning AS raised its position in shares of Humana by 5.5% in the fourth quarter. KLP Kapitalforvaltning AS now owns 46,070 shares of the insurance provider's stock valued at $11,835,000 after purchasing an additional 2,400 shares during the period. OVERSEA CHINESE BANKING Corp Ltd bought a new position in shares of Humana in the fourth quarter valued at about $272,000. Evergreen Capital Management LLC raised its position in shares of Humana by 145.0% in the fourth quarter. Evergreen Capital Management LLC now owns 2,288 shares of the insurance provider's stock valued at $588,000 after purchasing an additional 1,354 shares during the period. Finally, Zurcher Kantonalbank Zurich Cantonalbank raised its position in shares of Humana by 56.0% in the fourth quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 84,695 shares of the insurance provider's stock valued at $21,693,000 after purchasing an additional 30,402 shares during the period. 92.38% of the stock is owned by institutional investors.
Wall Street Analyst Weigh In
Several equities analysts have recently weighed in on the stock. Wolfe Research dropped their price objective on shares of Humana from $325.00 to $250.00 and set an "outperform" rating on the stock in a research report on Monday, April 6th. Morgan Stanley set a $146.00 price objective on shares of Humana in a research report on Thursday, February 12th. Wells Fargo & Company increased their price objective on shares of Humana from $206.00 to $227.00 and gave the company an "equal weight" rating in a research report on Tuesday, April 7th. Zacks Research lowered shares of Humana from a "hold" rating to a "strong sell" rating in a research report on Tuesday, April 14th. Finally, Cantor Fitzgerald lowered their price target on shares of Humana from $290.00 to $201.00 and set a "neutral" rating on the stock in a research report on Thursday, February 12th. Seven equities research analysts have rated the stock with a Buy rating, fifteen have issued a Hold rating and four have given a Sell rating to the stock. According to data from MarketBeat.com, the company has an average rating of "Hold" and an average target price of $222.09.
Check Out Our Latest Stock Analysis on Humana
Humana Price Performance
NYSE:HUM opened at $215.26 on Monday. Humana Inc. has a 52 week low of $163.11 and a 52 week high of $315.35. The firm has a market cap of $25.84 billion, a price-to-earnings ratio of 21.92, a P/E/G ratio of 2.31 and a beta of 0.44. The firm's 50-day simple moving average is $184.64 and its 200 day simple moving average is $228.15. The company has a debt-to-equity ratio of 0.70, a quick ratio of 2.00 and a current ratio of 2.00.
Humana (NYSE:HUM - Get Free Report) last released its quarterly earnings results on Wednesday, February 11th. The insurance provider reported ($3.96) EPS for the quarter, topping analysts' consensus estimates of ($4.01) by $0.05. Humana had a net margin of 0.92% and a return on equity of 11.43%. The business had revenue of $32.64 billion for the quarter, compared to analyst estimates of $32.08 billion. During the same period last year, the firm earned ($2.16) earnings per share. Humana's revenue for the quarter was up 11.3% compared to the same quarter last year. Humana has set its FY 2026 guidance at 9.000-9.000 EPS. As a group, sell-side analysts predict that Humana Inc. will post 9.05 earnings per share for the current year.
Humana Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Friday, June 26th will be paid a dividend of $0.885 per share. This represents a $3.54 dividend on an annualized basis and a yield of 1.6%. The ex-dividend date is Friday, June 26th. Humana's dividend payout ratio is presently 36.05%.
Insider Transactions at Humana
In other news, insider Sanjay K. Shetty acquired 810 shares of Humana stock in a transaction on Monday, February 23rd. The shares were purchased at an average cost of $185.21 per share, for a total transaction of $150,020.10. Following the completion of the purchase, the insider directly owned 11,657 shares of the company's stock, valued at approximately $2,158,992.97. This represents a 7.47% increase in their position. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. 0.20% of the stock is owned by insiders.
Humana Profile
(
Free Report)
Humana Inc NYSE: HUM is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana's products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.
In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.
Featured Articles
Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUM - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Humana, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Humana wasn't on the list.
While Humana currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link to see MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.